Exact Mass: 437.10490380000005

Exact Mass Matches: 437.10490380000005

Found 201 metabolites which its exact mass value is equals to given mass value 437.10490380000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Flavopiridol HCl

Flavopiridol hydrochloride

C21H21Cl2NO5 (437.07967160000004)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D006133 - Growth Substances > D006131 - Growth Inhibitors D000970 - Antineoplastic Agents

   

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

C21H25ClFN3O4 (437.15175320000003)


   

3-Phenylpropyl glucosinolate

{[(e)-(4-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}butylidene)amino]oxy}sulphonic acid

C16H23NO9S2 (437.0814188)


3-Phenylpropyl glucosinolate is found in brassicas. 3-Phenylpropyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 3-Phenylpropyl glucosinolate is found in horseradish and brassicas.

   

(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine

(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine

C20H18F7NO2 (437.1225692)


(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine is a metabolite of aprepitant. Aprepitant (Emend) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor. Aprepitant is manufactured by Merck & Co. under the brand name Emend for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting. It was approved by the FDA in 2003. (Wikipedia)

   

N-(4-(2-Chlorophenyl)-6,7-dimethyl-3-quinolyl)-N'-(2,4-difluorophenyl)urea

3-[4-(2-chlorophenyl)-6,7-dimethylquinolin-3-yl]-1-(2,4-difluorophenyl)urea

C24H18ClF2N3O (437.11063920000004)


   

N-Acetylcochinol-O-phosphate

({8-acetamido-13,14,15-trimethoxytricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-5-yl}oxy)phosphonic acid

C20H24NO8P (437.1239474)


   

Aleglitazar

2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid

C24H23NO5S (437.12968680000006)


   

2-[6,8-Dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

2-[6,8-Dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

C21H22Cl3N3O (437.08283720000003)


   

Estromustine

(13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) N,N-bis(2-chloroethyl)carbamate

C23H29Cl2NO3 (437.15243840000005)


   

Isavuconazole

4-{2-[3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile

C22H17F2N5OS (437.11218160000004)


   

Ravuconazole

4-{2-[3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile

C22H17F2N5OS (437.11218160000004)


   

Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate

Ethyl 3-({[(4-chlorophenyl)methyl][(5-nitrothiophen-2-yl)methyl]amino}methyl)pyrrolidine-1-carboxylic acid

C20H24ClN3O4S (437.1175974000001)


   

N-[2-[(R)-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-pyrrol-3-yl]benzamide

N-(2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphinyl}-1H-pyrrol-3-yl)benzenecarboximidic acid

C20H18F3N3O3S (437.10209140000006)


   
   

Disaccharide(Hex-Pen) + C4H5N3O2

Disaccharide(Hex-Pen) + C4H5N3O2

C15H23N3O12 (437.1281678)


Annotation level-3

   
   
   

jatropham 5-O-3)-beta-D-glucopyranoside>|Jatropham 5-O-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside

jatropham 5-O-3)-beta-D-glucopyranoside>|Jatropham 5-O-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside

C17H27NO12 (437.1533182)


   
   

(3S,4R,5S)-4-ethenyl-3-(beta-D-glucopyranosyloxy)-4,4a,5,6,7,8-hexahydro-8-oxo-3H-pyrano[3,4-c]pyridine-6-sulfonic acid

(3S,4R,5S)-4-ethenyl-3-(beta-D-glucopyranosyloxy)-4,4a,5,6,7,8-hexahydro-8-oxo-3H-pyrano[3,4-c]pyridine-6-sulfonic acid

C16H23NO11S (437.0991768)


   
   

Hysco

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, (1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, HYDROBROMIDE, HYDRATE (1:1:3), (.ALPHA.S)-

C17H21NO4.BrH.3H2O (437.10490380000005)


Scopolamine hydrobromide trihydrate appears as white orthorhombic sphenoidal crystals from water. pH of 0.05 molar solution: 5.85. (NTP, 1992) Scopolamine hydrobromide trihydrate is a hydrate that is the trihydrate form of scopolamine hydrobromide. It has a role as a mydriatic agent, a muscarinic antagonist, an anaesthesia adjuvant, an antispasmodic drug and an antiemetic. It contains a scopolamine hydrobromide (anhydrous). Scopolamine Hydrobromide is the hydrobromide salt form of scopolamine, a tropane alkaloid derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties. Structurally similar to acetylcholine, scopolamine antagonizes acetylcholine activity mediated by muscarinic receptors located on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. The agent is used to cause mydriasis, cycloplegia, to control the secretion of saliva and gastric acid, to slow gut motility, and prevent vomiting. An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78283 - Agent Affecting Organs of Special Senses > C29706 - Mydriatic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   

Ala Cys Met Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Ala Cys Asn Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Ala Met Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Ala Met Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Ala Asn Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Ala Asn Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Ala Met Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Ala Asn Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Cys Gly Arg

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Cys Asn Val

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Cys Arg Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Cys Val Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Asp Asn Ser

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Cys Asp Ser Asn

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Cys Gly Cys Arg

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Gly Met Gln

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Gly Gln Met

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Gly Arg Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Met Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Met Gly Gln

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetamido}-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Met Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Met Gln Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Cys Asn Ala Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Asn Cys Val

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Asn Asp Ser

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Cys Asn Met Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Asn Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Cys Asn Val Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Gln Gly Met

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Gln Met Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Cys Arg Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Arg Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Ser Asp Asn

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Cys Ser Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Cys Val Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Cys Val Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Asp Cys Asn Ser

(3S)-3-amino-3-{[(1R)-1-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asp Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C14H23N5O9S (437.1216428)


   

Asp Asn Cys Ser

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asp Asn Ser Cys

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asp Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H23N5O9S (437.1216428)


   

Asp Ser Asn Cys

(3S)-3-amino-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   
   
   

Gly Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Cys Met Gln

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Cys Gln Met

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Met Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Met Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Gln Cys Met

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Gln Met Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Gly Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Met Ala Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Met Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Met Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Met Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Ala Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Ala Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Cys Ala Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Cys Cys Val

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Cys Asp Ser

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asn Cys Met Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Cys Ser Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Asn Cys Val Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Asp Cys Ser

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asn Asp Ser Cys

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asn Met Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Met Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanoic acid

C15H27N5O6S2 (437.1402682)


   

Asn Ser Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Asn Ser Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Asn Val Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Gln Cys Gly Met

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Gln Cys Met Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Gln Gly Cys Met

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S2 (437.1402682)


   

Gln Gly Met Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Gln Met Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetic acid

C15H27N5O6S2 (437.1402682)


   

Gln Met Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Arg Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Arg Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Arg Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Ser Cys Asp Asn

(3S)-3-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Ser Cys Asn Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Ser Asp Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H23N5O9S (437.1216428)


   

Ser Asp Asn Cys

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Ser Asn Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C14H23N5O9S (437.1216428)


   

Ser Asn Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C14H23N5O9S (437.1216428)


   

Val Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Val Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Val Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S2 (437.1402682)


   

Nap-Asn-OH

(S)-5-amino-2-(3-(naphthalen-2-ylmethoxy)-4-nitrobenzamido)-5-oxopentanoic acid

C22H19N3O7 (437.12229440000004)


   

Asn-Nap-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(naphthalen-2-yl)butanoic acid

C22H19N3O7 (437.12229440000004)


   

3-Phenylpropyl glucosinolate

{[(E)-(4-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxy}sulfonic acid

C16H23NO9S2 (437.0814188)


   

Moxifloxacin HCl

Moxifloxacin hydrochloride

C21H25ClFN3O4 (437.15175320000003)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-5-(1,3-dioxoisoindol-2-yl)-6-fluorooxan-2-yl]methyl acetate

[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-5-(1,3-dioxoisoindol-2-yl)-6-fluorooxan-2-yl]methyl acetate

C20H20FNO9 (437.11220420000006)


   

Ravuconazole

4-[2-[3-(2,4-Difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile

C22H17F2N5OS (437.11218160000004)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(4-nitrophenyl) (2S)-6-amino-2-(phenylmethoxycarbonylamino)hexanoate,hydrochloride

(4-nitrophenyl) (2S)-6-amino-2-(phenylmethoxycarbonylamino)hexanoate,hydrochloride

C20H24ClN3O6 (437.13535540000004)


   

(4E)-5-{4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl}-(3S)-3-hydroxy-4-pentenoic acid

(4E)-5-{4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl}-(3S)-3-hydroxy-4-pentenoic acid

C20H24FN3O5S (437.14206260000003)


   

TRIS(ETHYLCYCLOPENTADIENYL)GADOLINIUM(I&

TRIS(ETHYLCYCLOPENTADIENYL)GADOLINIUM(I&

C21H27Gd (437.1353752)


   

4-[(2-chloro-4,6-dinitrophenyl)azo]-N,N-diethyl-2,5-dimethoxyaniline

4-[(2-chloro-4,6-dinitrophenyl)azo]-N,N-diethyl-2,5-dimethoxyaniline

C18H20ClN5O6 (437.11020500000006)


   

methyl 4-[1-[[(2,4-dichlorophenyl)amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]benzoate

methyl 4-[1-[[(2,4-dichlorophenyl)amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]benzoate

C21H21Cl2NO5 (437.07967160000004)


   
   

O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(tert-Butoxycarbonylmethoxyimino)acetate

O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(tert-Butoxycarbonylmethoxyimino)acetate

C15H24N3O8PS (437.10216740000004)


   

N-ALPHA-DANSYL-L-TRYPTOPHAN CYCLOHEXYLAMMONIUM SALT

N-ALPHA-DANSYL-L-TRYPTOPHAN CYCLOHEXYLAMMONIUM SALT

C23H23N3O4S (437.14091980000006)


   

(2S,3R)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)Morpholine

(2S,3R)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)Morpholine

C20H18F7NO2 (437.1225692)


   

2-Thiophenecarboxamide, 5-chloro-N-[3-[[3,5-dimethyl-4-(3-oxo-4-morpholinyl)phenyl]amino]-2-hydroxypropyl]

2-Thiophenecarboxamide, 5-chloro-N-[3-[[3,5-dimethyl-4-(3-oxo-4-morpholinyl)phenyl]amino]-2-hydroxypropyl]

C20H24ClN3O4S (437.1175974000001)


   

Cimetropium bromide

Cimetropium bromide

C21H28BrNO4 (437.12015880000007)


Cimetropium Bromide (DA-3177) is a mAChR antagonist for long-term treatment of irritable bowel syndrome.

   

Aleglitazar

Aleglitazar

C24H23NO5S (437.12968680000006)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

   

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,6-difluoro-alpha-methyl-L-phenylalanine

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,6-difluoro-alpha-methyl-L-phenylalanine

C25H21F2NO4 (437.143857)


   

N,N-Bis(4-sulfobutyl)-3,5-dimethylaniline disodium salt

N,N-Bis(4-sulfobutyl)-3,5-dimethylaniline disodium salt

C16H25NNa2O6S2 (437.091863)


   

Fominoben hydrochloride

Benzamide,N-[3-chloro-2-[[methyl[2-(4-morpholinyl)-2-oxoethyl]amino]methyl]phenyl]-,hydrochloride (1:1)

C21H25Cl2N3O3 (437.127288)


   

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3,4-DIFLUOROPHENYL)BUTANOIC ACID

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3,4-DIFLUOROPHENYL)BUTANOIC ACID

C25H21F2NO4 (437.143857)


   

LY 2119620

LY 2119620

C19H24ClN5O3S (437.1288304000001)


LY2119620 is a high-affinity muscarinic M2/M4 receptor agonist.

   

Fmoc-(S)-3-Amino-4-(3,4-Difluoro-Phenyl)-Butyric Acid

Fmoc-(S)-3-Amino-4-(3,4-Difluoro-Phenyl)-Butyric Acid

C25H21F2NO4 (437.143857)


   

Colazal

Balsalazide disodium

C17H17N3Na2O8 (437.0811002)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents D018501 - Antirheumatic Agents

   

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

C21H25ClFN3O4 (437.15175320000003)


   

2-DEOXY-2-PHTHALIMIDO-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL FLUORIDE

2-DEOXY-2-PHTHALIMIDO-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL FLUORIDE

C20H20FNO9 (437.11220420000006)


   

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine

[2R-[2ar*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine

C20H18F7NO2 (437.1225692)


   

(2R)-3-(3-chloro-4-hydroxyphenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

(2R)-3-(3-chloro-4-hydroxyphenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

C24H20ClNO5 (437.1029940000001)


   

Isavuconazole

Isavuconazole

C22H17F2N5OS (437.11218160000004)


J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

4-(4-Chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamido)-2,6-difluorobenzoic acid

4-(4-Chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamido)-2,6-difluorobenzoic acid

C22H22ClF2NO4 (437.12053460000004)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

Elenbecestat

Elenbecestat

C19H18F3N5O2S (437.1133244)


C78272 - Agent Affecting Nervous System

   

N-Acetylcochinol-O-phosphate

N-Acetylcochinol-O-phosphate

C20H24NO8P (437.1239474)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate

Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate

C20H24ClN3O4S (437.1175974000001)


   

2-Chloro-N-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-5-diethylsulfamoyl-benzamide

2-Chloro-N-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-5-diethylsulfamoyl-benzamide

C19H20ClN3O3S2 (437.06345600000003)


   

Ipsapirone hydrochloride

Ipsapirone hydrochloride

C19H24ClN5O3S (437.1288304000001)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

2-[6,8-Dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

2-[6,8-Dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide

C21H22Cl3N3O (437.08283720000003)


   

2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzo[b]thiophen-7-yl)propanoic acid

2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzo[b]thiophen-7-yl)propanoic acid

C24H23NO5S (437.12968680000006)


   

4-(Carbamoylamino)benzoic acid [2-(3-chloro-4-methylanilino)-2-oxo-1-phenylethyl] ester

4-(Carbamoylamino)benzoic acid [2-(3-chloro-4-methylanilino)-2-oxo-1-phenylethyl] ester

C23H20ClN3O4 (437.1142270000001)


   
   

2-chloro-5-(diethylsulfamoyl)-N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

2-chloro-5-(diethylsulfamoyl)-N-(2-methyl-1,3-benzothiazol-6-yl)benzamide

C19H20ClN3O3S2 (437.06345600000003)


   

N-Acetylcochinol-O-phosphate

({8-acetamido-13,14,15-trimethoxytricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,11,13-hexaen-5-yl}oxy)phosphonic acid

C20H24NO8P (437.1239474)


   

(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)butan-1-imine

(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)butan-1-imine

C15H25N4O7S2- (437.11646)


   

3,5,7,9,11,13,15,17,19-Nonaoxoicosanoate

3,5,7,9,11,13,15,17,19-Nonaoxoicosanoate

C20H21O11- (437.10838160000003)


   

10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-oxido-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione

10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-oxido-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione

C17H18N4O8P- (437.08622180000003)


   

indol-3-ylmethylisothiocyanate-[gamma-Glu-Cys}

indol-3-ylmethylisothiocyanate-[gamma-Glu-Cys}

C18H21N4O5S2- (437.0953316)


   

N-[2-[(R)-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-pyrrol-3-yl]benzamide

N-[2-[(R)-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-pyrrol-3-yl]benzamide

C20H18F3N3O3S (437.10209140000006)


   

(RS)-alpha-Cyano-3-phenoxybenzyl (RS)-2,2-dichloro-1-(4-ethoxyphenyl)cyclopropanecarboxylate

(RS)-alpha-Cyano-3-phenoxybenzyl (RS)-2,2-dichloro-1-(4-ethoxyphenyl)cyclopropanecarboxylate

C24H17Cl2NO3 (437.05854320000003)


   

Cladoniamide A

Cladoniamide A

C22H16ClN3O5 (437.07784360000005)


An organic heterohexacyclic compound that is cladoniamide B in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

   

4-[5-(3-Methoxyphenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide

4-[5-(3-Methoxyphenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide

C23H23N3O4S (437.14091980000006)


   

4-({[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene}amino)-5-(4-pyridinyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-({[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene}amino)-5-(4-pyridinyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

C24H19N7S (437.14225740000006)


   

N-[1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinyl]carbamic acid tert-butyl ester

N-[1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinyl]carbamic acid tert-butyl ester

C19H24BrN3O2S (437.0772504)


   

N-(1,3-benzodioxol-5-yl)-2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]acetamide

N-(1,3-benzodioxol-5-yl)-2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]acetamide

C19H20ClN3O5S (437.0812140000001)


   

6-[2-(2-methoxyphenyl)imino-3-(2-oxolanylmethyl)-4-thiazolyl]-4H-1,4-benzoxazin-3-one

6-[2-(2-methoxyphenyl)imino-3-(2-oxolanylmethyl)-4-thiazolyl]-4H-1,4-benzoxazin-3-one

C23H23N3O4S (437.14091980000006)


   

N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide

N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide

C20H27N3O4S2 (437.14429020000006)


   

2-[7-chloro-2,3-dioxo-4-(phenylmethyl)-1-quinoxalinyl]-N-(3-fluorophenyl)acetamide

2-[7-chloro-2,3-dioxo-4-(phenylmethyl)-1-quinoxalinyl]-N-(3-fluorophenyl)acetamide

C23H17ClFN3O3 (437.0942414)


   

5-Nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester

5-Nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester

C18H19N3O8S (437.0892814)


   

N-[2-(3-chlorophenyl)ethyl]-2-[[3-cyano-6-(3-methoxyphenyl)-2-pyridinyl]thio]acetamide

N-[2-(3-chlorophenyl)ethyl]-2-[[3-cyano-6-(3-methoxyphenyl)-2-pyridinyl]thio]acetamide

C23H20ClN3O2S (437.09646900000007)


   

N-(5-phenyl-1,3,4-thiadiazol-2-yl)-2-[[4-propyl-5-(2-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

N-(5-phenyl-1,3,4-thiadiazol-2-yl)-2-[[4-propyl-5-(2-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

C20H19N7OS2 (437.1092444)


   

(4-Difluoromethoxy-benzylidene)-[6-(4-difluoromethoxy-phenyl)-2,3-dihydro-imidazo[2,1-b]thiazol-5-yl]-amine

(4-Difluoromethoxy-benzylidene)-[6-(4-difluoromethoxy-phenyl)-2,3-dihydro-imidazo[2,1-b]thiazol-5-yl]-amine

C20H15F4N3O2S (437.0821058)


   

1-(4-fluorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea

1-(4-fluorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea

C23H20FN3O3S (437.1209342000001)


   
   

6-O-benzyl-2-deoxyguanosine 5-monophosphate

6-O-benzyl-2-deoxyguanosine 5-monophosphate

C17H20N5O7P (437.11003000000005)


   

2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid

2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid

C20H20FNO7S (437.09444620000005)


   

2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H20FNO7S (437.09444620000005)


   

2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H20FNO7S (437.09444620000005)


   

2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H20FNO7S (437.09444620000005)


   

3-(3,4-dimethoxyphenyl)-N-{2-[3-methoxy-4-(sulfooxy)phenyl]ethyl}prop-2-enimidic acid

3-(3,4-dimethoxyphenyl)-N-{2-[3-methoxy-4-(sulfooxy)phenyl]ethyl}prop-2-enimidic acid

C20H23NO8S (437.11443180000003)


   
   

GW438014A

GW438014A

C23H23N3O4S (437.14091980000006)


GW438014A is a potent and selective NPY-Y5 receptor antagonist. GW438014A inhibits food intake and reduces body weight gain in obese rodents[1].

   

3-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylphenyl)-4-(3-methylbut-2-en-1-yl)-3h-isoindole-1,5,7-triol

3-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylphenyl)-4-(3-methylbut-2-en-1-yl)-3h-isoindole-1,5,7-triol

C21H21Cl2NO5 (437.07967160000004)


   

7-chloro-11,15-dihydroxy-23-methoxy-13-methyl-3,13,16-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(23),2(10),4,6,8,17,19,21-octaene-12,14-dione

7-chloro-11,15-dihydroxy-23-methoxy-13-methyl-3,13,16-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(23),2(10),4,6,8,17,19,21-octaene-12,14-dione

C22H16ClN3O5 (437.07784360000005)


   

2-amino-n-(1-{[3-(dichloromethyl)-6,8-dihydroxy-3-methyl-1-oxo-4a,5,6,7-tetrahydro-4h-2-benzopyran-4-yl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

2-amino-n-(1-{[3-(dichloromethyl)-6,8-dihydroxy-3-methyl-1-oxo-4a,5,6,7-tetrahydro-4h-2-benzopyran-4-yl]-c-hydroxycarbonimidoyl}ethyl)propanimidic acid

C17H25Cl2N3O6 (437.11203300000005)